Aspirin resistance in cardiovascular disease

BMJ

Volumn 336, Issue 7637, 2008, Pages 166-167

  Biondi Zoccai, Giuseppe ^a   Lotrionte, Marzia ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; HEPARIN; TIROFIBAN;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DATA ANALYSIS; EDITORIAL; EXTERNAL VALIDITY; HUMAN; KIDNEY FAILURE; MEDICAL RESEARCH; MORBIDITY; MORTALITY; NORMAL DISTRIBUTION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; THROMBOCYTE ACTIVATION; TREATMENT OUTCOME; UNIVARIATE ANALYSIS;

ANTICOAGULANTS; ASPIRIN; CARDIOVASCULAR DISEASES; DRUG RESISTANCE; HUMANS; PROGNOSIS; RISK FACTORS;

EID: 38949160368     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39405.635498.80     Document Type: Editorial

References (6)

1. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.
2. Krasopoulos G, Brister SJ, Beattie WS, Buchanan MR. Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis. BMJ 2008 doi: 10.1136/bmj.39430.529549.BE.
3. Campo G, Valgimigli M, Gemmati D, Percoco G, Catozzi L, Frangione A, et al. Poor responsiveness to clopidogrel: drug-specific or class-effect mechanism? Evidence from a clopidogrel-to-ticlopidine crossover study. J Am Coll Cardiol 2007;50:1132-7.
4. Lordkipanidzé M, Pharand C, Schampaert E, Turgeon J, Palisaitis DA, Diodati JG. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease. Eur Heart J 2007;28:1702-8.
5. Barnes GD, Li J, Kline-Rogers E, Vedre A, Armstrong DF, Froehlich JB, et al. Dual antiplatelet agent failure: a new syndrome or clinical nonentity? Am Heart J 2007;154:732-5.
6. Snoep JD, Hovens MM, Eikenboom JC, van der Bom JG, Huisman MV. Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis. Arch Intern Med 2007;167:1593-9.